共 106 条
[1]
Kwak EL(2010)Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 1693-1703
[2]
Bang YJ(2007)Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 561-566
[3]
Camidge DR(2008)Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts Clin Cancer Res 14 6618-6624
[4]
Shaw AT(2009)The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS Cancer 115 1723-1733
[5]
Solomon B(2015)Future options for Lung Cancer. 87 211-219
[6]
Soda M(2016)-positive non-small cell lung cancer J Clin Oncol 34 107-109
[7]
Choi YL(2013)CNS metastases in patients with non-small-cell lung cancer and ALK gene rearrangement PLoS One 8 e64821-859
[8]
Enomoto M(2013)Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, Immunohistochemistry, and real-time quantitative RT-PCR on paraffin-embedded tissues J Thorac Oncol. 8 823-74
[9]
Takada S(2014)Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology PLoS One 9 e101551-803
[10]
Yamashita Y(2014)Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR Transl Lung Cancer Res. 3 70-2034